Trials / Conditions / Discoid Lupus Erythematosus

Discoid Lupus Erythematosus

14 registered clinical trials studyying Discoid Lupus Erythematosus — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Study to Evaluate the Efficacy of Ruxolitinib 1.5% Cream in Adult Subjects with Discoid Lupus Erythematosus NCT06261021	Innovaderm Research Inc.	Phase 2
Terminated	Study of Daxdilimab (HZN-7734) in Participants With Moderate-to-Severe Primary Discoid Lupus Erythematosus NCT05591222	Amgen	Phase 2
Completed	Study of Ruxolitinib Cream for the Treatment of Discoid Lupus Erythematosus NCT04908280	University of Rochester	Phase 2
Completed	Topical Nicotinamide in Treatment of DLE NCT05362188	Al-Azhar University	EARLY_Phase 1
Withdrawn	A Study to Assess the Safety and Efficacy of Secukinumab in Alleviating Symptoms of Discoid Lupus Erythematosu NCT03866317	Massachusetts General Hospital	Phase 2
Terminated	Efficacy and Safety of Delgocitinib Cream in Discoid Lupus Erythematosus. NCT03958955	LEO Pharma	Phase 2
Terminated	Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SL NCT03159936	Tufts Medical Center	EARLY_Phase 1
Completed	Pilot Tape Harvesting Study NCT02125695	Biogen	—
Completed	Safety Study of Clinical and Immune Effects of Phosphodiesterase 4 (PDE-4) Inhibitor in Cutaneous Lupus Patien NCT00708916	NYU Langone Health	Phase 1 / Phase 2
Completed	Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions NCT00625521	Astion Pharma A/S	Phase 2
Completed	Expression of Fas Protein in Skin Biopsies of Participants With Scarring Alopecia NCT00691769	Wake Forest University	—
Completed	Comparing the Therapeutic Efficacy of Pimecrolimus Cream With Betamethasone Cream for Discoid Lupus Erythemato NCT00608673	Shahid Beheshti University of Medical Sciences	N/A
Completed	A Pilot Trial of Topical Thalidomide for the Management of Chronic Discoid Lupus Erythematosus NCT00001680	National Cancer Institute (NCI)	Phase 2
Completed	Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions (2) NCT00625157	Astion Pharma A/S	Phase 2